Stephen P. Schoenberger spends much of his time researching Cytotoxic T cell, CD8, Cell biology, Immunology and Priming. IL-2 receptor is the focus of his Cytotoxic T cell research. His work investigates the relationship between CD8 and topics such as Homeostasis that intersect with problems in Spleen and Cytokine.
His work deals with themes such as Acquired immune system, Jurkat cells, Immunological synapse and Actin cytoskeleton, which intersect with Cell biology. His Immunology study incorporates themes from Cell division and CD40. Stephen P. Schoenberger has included themes like T lymphocyte, CTL*, Immune tolerance and Antigen-presenting cell in his Priming study.
The scientist’s investigation covers issues in Immunology, Cytotoxic T cell, Cell biology, T cell and CD8. Antibody and Cell growth is closely connected to CD40 in his research, which is encompassed under the umbrella topic of Immunology. The various areas that he examines in his Cytotoxic T cell study include Epitope and Priming.
As part of one scientific family, Stephen P. Schoenberger deals mainly with the area of Cell biology, narrowing it down to issues related to the CD28, and often ZAP70. In his work, Humoral immunity is strongly intertwined with Bone marrow, which is a subfield of T cell. His CD8 research incorporates themes from Interleukin 2 and Homeostasis.
Stephen P. Schoenberger mainly investigates Immune system, Cytotoxic T cell, Immunology, Antigen and CD8. His research in the fields of Acquired immune system, Tumor microenvironment and Cancer immunotherapy overlaps with other disciplines such as Irreversible electroporation. His work carried out in the field of Cytotoxic T cell brings together such families of science as Epitope, T cell and Cell biology.
His study in Antigen-presenting cell and IL-2 receptor is carried out as part of his studies in T cell. In the subject of general Antigen, his work in Major histocompatibility complex is often linked to Time optimal, thereby combining diverse domains of study. Stephen P. Schoenberger does research in CD8, focusing on CTL* specifically.
His primary areas of investigation include Immune system, Antigen, Immunology, Cytotoxic T cell and T cell. Stephen P. Schoenberger interconnects Clinical efficacy and Cancer in the investigation of issues within Immune system. His biological study spans a wide range of topics, including B cell, Microbiology, B-1 cell and Glycan.
His work in Immunotherapy, Major histocompatibility complex, Cancer immunotherapy, Epitope and Follicular dendritic cells is related to Immunology. His research on Cytotoxic T cell frequently links to adjacent areas such as Plasmacytoid dendritic cell. As part of his studies on T cell, he often connects relevant areas like Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
S. P. Schoenberger;R. E. M. Toes;E. I. H. Van Der Voort;R. Offringa.
CD4 + T cells are required for secondary expansion and memory in CD8 + T lymphocytes
Edith M. Janssen;Edward E. Lemmens;Tom Wolfe;Urs Christen.
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation
Marianne J. B. van Stipdonk;Edward E. Lemmens;Stephen P. Schoenberger.
Nature Immunology (2001)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter;Mathias Vormehr;Niels van de Roemer;Mustafa Diken.
CD4 + T-cell help controls CD8 + T-cell memory via TRAIL-mediated activation-induced cell death
Edith M. Janssen;Nathalie M. Droin;Edward E. Lemmens;Michael J. Pinkoski.
Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation
Shane Crotty;Robert J Johnston;Robert J Johnston;Stephen P Schoenberger.
Nature Immunology (2010)
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
Diehl L;den Boer At;Schoenberger Sp;van der Voort Ei.
Nature Medicine (1999)
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.
Eduardo M. Sotomayor;Ivan M Borrello;Erev Tubb;Frédérique Marie Rattis.
Nature Medicine (1999)
The immune epitope database and analysis resource: from vision to blueprint.
Bjoern Peters;John Sidney;Phil Bourne;Huynh-Hoa Bui.
PLOS Biology (2005)
A Critical Role for Stat3 Signaling in Immune Tolerance
Fengdong Cheng;Hong-Wei Wang;Alex Cuenca;Mei Huang.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: